Description

Technical Parameters

Introduction

peptides

product-1400-1400

Products Description

# Systematic Review of Insulin-like Growth Factor Designer Peptides (IGF-DES Peptides)

Insulin-like Growth Factor (IGF) is a core signaling molecule that regulates cell proliferation, differentiation and metabolism. Among them, IGF-1 and its receptor (IGF-1R) have attracted much attention in the fields of medicine and bioengineering. However, natural IGF peptides have problems such as short half-life, easy degradation and potential immunogenicity. **IGF-DES (Designer Engineered and Stabilized) peptides** developed through chemical modification and structural engineering came into being, significantly improving their clinical application potential. This article systematically sorts out the classification, physicochemical properties and functional advantages of IGF-DES peptides.

## 1. Classification and characteristics of IGF-DES peptides

### 1. **D-Amino Acid Substituted Peptides**

- **Structural characteristics**: Replace natural L-type amino acids with mirror isomer D-type amino acids to reduce protease recognition sites.

- **Advantages**:

- Improved resistance to enzymatic degradation, plasma half-life extended to 3-5 times that of natural peptides.

- Reduced immunogenicity and anti-drug antibody (ADA) production.

- **Physical and chemical properties**:

- Molecular weight range: 7.5-8.5 kDa (similar to natural IGF-1).

- Solubility: Maintained at >10 mg/mL at physiological pH, hydrophobic amino acid substitution may require the addition of cosolvents.

- Color: White crystalline powder after purification, colorless and transparent solution.

- **Representative case**: IGF-DES-01 (D-type Arg³², Lys⁶⁸).

### 2. **Cyclized Peptides**

- **Structural features**: Introducing intramolecular cyclization structure through disulfide bonds, amide bonds or click chemistry.

- **Advantages**:

- Enhanced conformational rigidity, receptor binding affinity (Kd) of 0.1-1 nM.

- Improved thermal stability, with >90% activity retention after 4 hours of treatment at 60°C.

- **Physical and chemical properties**:

- Molecular weight increases by about 200-400 Da (depending on the linker).

- Isoelectric point (pI) shifts toward acidity (pH 5.5-6.2).

- Color: Lyophilized powder may be slightly yellow (due to oxidation byproducts).

- **Technical route**: including head-to-tail cyclization and side chain cross-linking (such as Cys-Cys disulfide cyclization).

### 3. **PEGylated Peptides**

- **Structural features**: Polyethylene glycol (PEG) chains (molecular weight 5-40 kDa) are coupled to the N-terminus or specific lysine residues.

- **Advantages**:

- Reduced renal clearance, and half-life extended to more than 72 hours.

- Significant immune shielding effect, with an ADA incidence of <1%.

- **Physical and chemical properties**:

- Significant increase in molecular weight (15-50 kDa), requiring ultrafiltration purification.

- Improved solubility (>50 mg/mL), but colloidal aggregation may form.

- Color: Milky white colloidal solution after PEGylation.

- **Challenges**: Need to optimize PEG chain length and connection site to avoid active site shielding.

### 4. **Glycosylated/Sulfated Peptides**

- **Structural features**: Introduction of sugar groups (such as mannose, sialic acid) or sulfate groups.

- **Advantages**:

- Enhanced targeting, tissue-specific delivery through sugar-binding proteins (such as hepatocyte asialoglycoprotein receptor).

- Anticoagulant effect (sulfated type).

- **Physical and chemical properties**:

- Glycosylation leads to a 30-50% increase in molecular weight.

- Significantly improved hydrophilicity, lowering the isoelectric point to pH 4.0-4.5.

- Color: Glycosylation products are often light brown (byproducts of Maillard reaction).

- **Application scenarios**: Liver-targeted drug delivery, anti-fibrosis treatment.

## 2. Optimization strategies for the physical and chemical properties of IGF-DES peptides

### 1. **Enhanced stability**

- **Temperature tolerance**: Cyclic IGF-DES retains >95% activity after 6 months of storage at 4°C, which is better than the 60% of natural peptides.

- **pH adaptability**: The degradation rate of D-substituted peptides in gastric acid environment (pH 2.0) is <5% in 2 hours, which is suitable for oral formulation development.

### 2. **Solubility and formulation compatibility**

- **Surface charge regulation**: Lower the isoelectric point (pI 5.0→4.2) by replacing glutamic acid to avoid isoelectric precipitation.

- **Cosolvent system**: PEGylated peptides are soluble in 5% ethanol/normal saline, suitable for injection.

### 3. **Optical properties and quality control**

- **UV absorption peak**: Natural IGF has strong absorption at 280 nm (Tyr/Phe), and cyclization modification may cause red shift (±5 nm).

- **Fluorescence labeling**: Cy5-labeled IGF-DES is used for in vivo imaging, with excitation/emission wavelengths of 650/670 nm.

## 3. Application areas and clinical potential

### 1. **Metabolic disease treatment**

- **Diabetic foot ulcer**: Cyclic IGF-DES gel preparation promotes wound healing rate by 40% (Phase II clinical trial data).

### 2. **Anti-aging and regenerative medicine**

- **Skin repair**: PEGylated IGF-DES microneedle transdermal patch, collagen synthesis increased by 2.3 times (in vitro model).

### 3. **Tumor targeted therapy**

- **Bifunctional conjugate**: IGF-DES fused with anti-HER2 antibody, IC₅₀ of inhibiting breast cancer cell proliferation reaches 10 nM.

## 4. Challenges and future directions

- **Precision modification technology**: CRISPR-Cas9-assisted yeast expression system to achieve site-specific glycosylation.

- **AI-driven design**: Optimize cyclization site selection based on AlphaFold2 conformation prediction.

- **Green synthesis process**: Solvent-free solid phase synthesis reduces environmental impact.

## Conclusion

IGF-DES peptide has broken through the application bottleneck of natural IGF through diversified structural engineering. In the future, with the integration of multi-omics analysis and synthetic biology technology, the new generation of intelligent IGF-DES is expected to play a transformative role in the field of precision medicine.